As of Thursday, May 15, iTeos Therapeutics, Inc.’s ITOS share price has surged by 5.79%, which has investors questioning if ...

As of Wednesday, May 07, iTeos Therapeutics, Inc.’s ITOS share price has dipped by 5.74%, which has investors questioning if this is right time to buy.

Recently, a new class of therapeutics that disable the neonatal Fc receptor (FcRn), which protects IgG from degradation, has emerged to treat IgG-mediated autoimmune disease. 4,5 Here, we review ...

Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost ...

Dynamic remodeling of the endomembrane system is a core biological process essential for maintaining cellular ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

Previous studies have shown that GIPR agonists act in the brain independently of the GLP-1 receptor. To achieve this, they use neurons that release the inhibitory neurotransmitter gamma aminobutyric ...

Masks depicting Dai Yongge as a clown and the carrying of a Reading FC coffin have also been on show at the SCL Stadium during the season. Many Reading fans have been frustrated by what they ...

The U.S. FDA approval of Johnson & Johnson’s Imaavy (nipocalimab-aahu) for myasthenia gravis brings the monoclonal antibody into a treatment space that has plenty of competition. The human Fc receptor ...